A Pre-post Intervention Study Evaluating Home-based Management of Patients With Chronic Obstructive Pulmonary Disease or Community Acquired Pneumonia
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 主要终点
- Number of participants with a hospital readmission
研究概览
简要总结
Risk of rehospitalization within 30 days of discharge is higher than 20% in patients with chronic obstructive pulmonary disease (COPD) and up to 20% for patients with community acquired pneumonia (CAP). This pre-post intervention study aims to quantify the impact of continuous remote patient monitoring (RPM) on rates of hospital readmission for patients presenting with CAP or exacerbation of COPD and compare the intervention group to historical controls that did not have access to the intervention. We hypothesize that an intervention combining remote patient monitoring with the remote clinical services and escalation pathways available at SSH (including the Mobile Integrated Health (MIH) program) will reduce hospital readmission within the 30 days following hospital discharge compared to standard of care in this population.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •21 years or older
- •confirmed diagnosis of moderate-severe COPD or community acquired pneumonia
- •attendance at South Shore Hospital with an exacerbation of COPD / CAP
- •fit for discharge to home
排除标准
- •suspicion of COVID-19 or confirmed COVID-19 positive
- •life-threatening exacerbation requiring invasive ventilation or prolonged stay in critical care (> 24 hours)
- •unable/unwilling to use Current Health
- •bilateral axillary lymph node dissection
- •persistent atrial fibrillation
- •heavy tattooing on upper arms
- •discharged to skilled nursing facility
- •no access to home or mobile telephone
结局指标
主要结局
Number of participants with a hospital readmission
时间窗: up to 30 days
次要结局
- Rate of medication adherence(up to 30 days)
- Progression of Disease(up to 30 days)
- Rate of Mortality(up to 30 days)
- Time to service use(up to 30 days)
- Rate of clinical visits(up to 30 days)
- Length of Stay(up to 30 days)